Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-802-7 | CAS number: -
Endpoint summary
Administrative data
Description of key information
The oral toxicity of the substances was investigated according to OECD Guideline 401 in a read across approach. The test substance did not cause toxic symptoms in doses up to 50000 mg/kg b.w.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 1997-06-23 to 1997-08-25
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study, read-across
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH, Sulzfeld, Germany
- Age at study initiation: 39 days (males); 48 days (females)
- Weight at study initiation: 164 - 200 g (males); 155 - 184 g (females)
- Fasting period before study: approx. 16 hours
- Housing: in groups of 2 - 3 animals in Makrolon cages type III on granulated textured wood bedding
- Diet (e.g. ad libitum): Altromin 1324 (Standard diet for rats and mice) ad libitum, supplied by Altromin GmbH, Lage/Lippe, Germany
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 60 ± 20
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: no data - Route of administration:
- oral: gavage
- Vehicle:
- other: 0.8 % aqueous hydroxypropylmethylcellulose gel (METHOCEL E 4 M, Synopharm, Barsbüttel, Germany)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: The test substance was diluted to the appropriate concentration for dose levels 1 - 4 (2000, 6000, 10000 and 20000 mg/kg), for group 5 (50000 mg/kg) the test substance was used as supplied), no further details mentioned.
- Amount of vehicle (if gavage): no data
- Justification for choice of vehicle: not justified
- Lot/batch no. (if required): MM90100512E
- Purity: no data
MAXIMUM DOSE VOLUME APPLIED: group 1 - 4: 20 mL/kg bw; group 5: 50 mL/kg bw - Doses:
- 2000 / 6000 / 10000 / 20000 / 50000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations were performed before and immediately, 5, 15, 30 and 60 min, as well as 3, 6 and 24 h after administration and thereafter daily. Individual boy weights were recorded before administration of the substtance , thereafter in weekly intervalls.
- Necropsy of survivors performed: yes
- Other examinations performed: Clinical signs concerning changes of skin and fur, eyes and mucous membranes, respiratory and the circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern were examined, attention was also paid to possible tremor, convulsions, salivation, diarrhoea, lethargy, sleep and coma. - Statistics:
- No statistics performed, due to lack of mortality in this study.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 50 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortality occurred
- Clinical signs:
- no clinical signs observed
- Body weight:
- normal body weight gain achieved
- Gross pathology:
- no test substance related findings noted
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the present test condition a single oral administration of up to 50000 mg/kg b.w. to rats revealed no toxic symptoms. 50000 mg/kg equivalent to an application volume of 50 mL/kg was the highest reasonable application volume. The test substance was classified to be relatively non-toxic.
- Executive summary:
The test item was investigated according to OECD Guideline 401. The test subsatnce was administered to once orally to male and female Sprague-Dawley rats by gavage a doses up to 50000 mg/kg b.w. Subsequently, observations of effects and deaths were made. All surviving animals were observed for a period of 14 days.
Under the present test condition a single oral administration of up to 50000 mg/kg b.w. to rats revealed no toxic symptoms. 50000 mg/kg equivalent to an application volume of 50 mL/kg was the highest reasonable application volume. The test substance was classified to be relatively non-toxic.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- 1. HYPOTHESIS FOR THE ANALOGUE APPROACH
This read across is based on the hypothesis that source and target substance have similar toxicological and ecotoxicological properties, because
- they are manufactured from similar/identical precursors under similar conditions
- they share structural similarities with common functional groups: ester bonds and fatty alcohol chains varying in length
Therefore, read across from the existing physical-chemical, toxicological and ecotoxicological studies on the source substance is considered as an appropriate adaptation to the standard information requirements of the REACH Regulation for the target substance , in accordance with the provisions of Annex XI, 1.5 of the REACH Regulation.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
The source substance 2-Hydroxypropan-1,2,3-tricarboxylic acid, tri (hexyl, octyl, decyl esters) is a UVCB substance manufactured from 2-Hydroxypropan-1,2,3-tricarboxylic acid and C6-10 fatty alcohols.
The target substance Reaction mass of didodecyl hydrogen citrate and tridodecyl 2-hydroxypropane-1,2,3-tricarboxylate is a multi constituent substance manufactured from 2-Hydroxypropan-1,2,3-tricarboxylic acid and 1-dodecyl alcohol.
3. ANALOGUE APPROACH JUSTIFICATION
The read-across hypothesis is based on structural similarity of the target and source substance. Based on available experimental data, including key physicochemical properties and a genotoxicity study, the read-across strategy is supported by a similar toxicological profile of the target and source substance.
The respective reliable data (RL 1 or 2) are summarized in the data matrix; robust study summaries are included in the Technical Dossier in the respective sections.
The read-across from the source substance is justified:
a) Based on the information given in section 1, it can be concluded that the substances are similar in structure, since they are manufactured from similar or identical precursors under similar conditions and all contain the same functional groups. Thus a common mode of action can be assumed.
c) The only difference within the two substances is a (minor) variation in the chain length of the alcohols used for manufacture, which is not expected to have a relevant impact on intrinsic toxic or ecotoxic activity and environmental fate.
4. DATA MATRIX
See document under "Attached justification". - Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- other: 0.8 % aqueous hydroxypropylmethylcellulose gel (METHOCEL E 4 M, Synopharm, Barsbüttel, Germany)
- Doses:
- 2000 / 6000 / 10000 / 20000 / 50000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 50 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortality occurred
- Clinical signs:
- no clinical signs observed
- Body weight:
- normal body weight gain achieved
- Gross pathology:
- no test substance related findings noted
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the present test condition a single oral administration of up to 50000 mg/kg b.w. to rats revealed no toxic symptoms. 50000 mg/kg equivalent to an application volume of 50 mL/kg was the highest reasonable application volume. The test substance was classified to be relatively non-toxic.
- Executive summary:
The test item was investigated according to OECD Guideline 401. The test subsatnce was administered to once orally to male and female Sprague-Dawley rats by gavage a doses up to 50000 mg/kg b.w. Subsequently, observations of effects and deaths were made. All surviving animals were observed for a period of 14 days.
Under the present test condition a single oral administration of up to 50000 mg/kg b.w. to rats revealed no toxic symptoms. 50000 mg/kg equivalent to an application volume of 50 mL/kg was the highest reasonable application volume. The test substance was classified to be relatively non-toxic.
Referenceopen allclose all
Table: Number of animals dead [and with evident toxicity] [and time range within which mortality occurred]
Dose |
Mortality (# dead/total) |
Time range of deaths (hours) |
Number with evident toxicity(#/total) |
||||
Male |
Female |
Combined |
Male |
Female |
Combined |
||
2000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
6000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
10000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
20000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
50000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
Table: Number of animals dead [and with evident toxicity] [and time range within which mortality occurred]
Dose |
Mortality (# dead/total) |
Time range of deaths (hours) |
Number with evident toxicity(#/total) |
||||
Male |
Female |
Combined |
Male |
Female |
Combined |
||
2000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
6000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
10000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
20000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
50000 |
0/5 |
0/5 |
0/10 |
- |
0/5 |
0/5 |
0/10 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 50 000 mg/kg bw
Additional information
Justification for classification or non-classification
The acute oral toxicity was investigated according to OECD Guideline 401. Oral administration of up to 50000 mg/kg b.w. to rats revealed no toxic symptoms.
No data are available on inhalative toxicity. However, the very low vapour pressure of the substance does not indicate an inhalative hazard.
No data are available on dermal toxicity. However, taking into account the very low oral toxicity, a low dermal can be assumed as well.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
